Elucidata

Elucidata builds program-specific AI solutions that help biopharma R&D teams identify targets they can confidently pursue, as a full-stack target validation partner for data, bioinformatics and infrastructure. Its Polly platform harmonizes multi-modal R&D data from proprietary and public sources into quality-checked data products.

AI and Multi-Omics Discovery

• Narrow and score targets with a co-built, program-specific target decision system: Elucidata harmonizes a client’s omics, assay and experimental data with curated evidence from 20+ public sources, and Polly Knowledge Graph connects genetics, transcriptomics, proteomics and disease mechanisms for every target.
• Analyze multi-omics data through custom bioinformatics pipelines and machine-learning models for target identification, biomarker discovery, cell type annotation, and patient stratification. Polly Co-Scientist adds guided, conversational workflows for analyzing datasets and generating hypotheses.

Custom AI Model Development

• Build predictive models by gathering analysis and data requirements, developing training datasets and models, training them, and deploying them to generate predictions.
• Train models across decentralized data sources through federated learning without centralizing sensitive data.

Data Integration and Analytical Infrastructure

• Integrate life-sciences data by designing and implementing customized ETL pipelines with Nextflow, Prefect, or Snakemake for specific workflow and infrastructure needs. Polly Scout finds and scores candidate public datasets before harmonization, and Polly Xtract turns unstructured documents, including EMR/EHR exports, into schema-enforced records.
• When Elucidata takes on a customer’s computational infrastructure layer, Polly Atlas is the structured data environment and schema that downstream pipelines, dashboards and AI workflows query.

Best Fit

• Discovery and data science teams that need multi-omics analysis, custom machine-learning development, or target decision support.
• Organizations that need customized data pipelines, structured analytical infrastructure, or cohort identification from genomics, treatment, and observational datasets.